Nov 13, 2024

Philips empowers Indian interventionalists with the introduction of world-class new Azurion

Product extends state-of-the-art imaging capabilities, supporting complex treatments across specialities

Bengaluru, November 13, 2024 – Philips India, a leader in health technology and innovation, introduced the new Azurion to specialist interventionalist across cardiology, neurology, vascular as well as surgery in India. Designed to streamline neurovascular procedures and help care teams make the right decisions faster, treat more patients, and achieve better outcomes, the new interventional system features enhanced C-arm rotation and angulation (imaging angles). It also provides parking facilities that allow rapid transitioning between 2D to 3D imaging, comprehensive table-side control that eliminates the need to leave the sterile field, automatic beam rotation to obtain correctly oriented images for every angulation and rotation, and a new head immobilizer to support enhanced stroke care.

Additionally, Philips is maximizing the uptime of its angio suite solutions by using AI and machine learning to monitor system performance through the new remote connection services of the Philips Service Hub. These services communicate, monitor, and proactively respond to potential service issues in advance so that pre-emptive action can be taken.

The new Azurion, set-up at Philips Innovation Campus, Bengaluru - the company’s largest innovation hub globally - was showcased to 80 interventionalists from across India. “At Philips India, we are committed to advancing health technology to improve lives and healthcare outcomes across the country. The new Azurion, empowers our customers to transform how patients are treated for a broad range of critical illnesses, including cardiovascular and neurovascular diseases. Philips, through its significant investments, is committed in developing a world class healthcare ecosystem in India by way of R&D, software, services and manufacturing,” said Bharath Sesha, Managing Director, Philips Indian Subcontinent.

The new Azurion system brings state of the art imaging capabilities and flexible ergonomic gantry positioning to optimize clinician workflow, ensuring faster and more precise treatment for the patients. This focus on enhanced imaging and efficiency reflects Philips’ commitment to improving patient outcomes in India. By allowing interventionalists to treat more patients, more efficiently, with potentially better outcomes, the Philips new Azurion enhances both the staff and patient experience and contributes to lower cost of care.

“Philips Innovation Campus has been evolving steadily and I can confidently state that today we are seen as drivers of end-to-end innovation value chain. This implies that we have been able to collectively work towards value creation for our businesses globally, harnessing our well-established software capabilities along with deep Artificial Intelligence in healthcare domain. Further, being a microcosm of Philips global business helps us to accelerate innovations by leveraging our cross-businesses and cross-functional teams within and co-create with teams outside of India as well. The new Azurion system is an outcome of such a collaborative effort. Our teams are also continuously engaging with healthcare leaders and technicians to develop solutions that can address the unique healthcare challenges in India and around the world,” said Arvind Vaishnav, Head, Philips Innovation Campus and Innovation Partnerships – Growth region, Philips.

“It was interesting to see innovative solutions at Philips recently. I am particularly looking forward to the potentially game-changing Direct-to-Angio-Suite (DTAS) feature. This innovative technology will revolutionize stroke care by significantly reducing door-to-puncture time, thereby, improving patient outcomes and saving lives. The new Azurion evidently has advanced capabilities and will enable the interventionalist to provide more efficient and effective treatment, enhancing the quality of life of patients,” said Dr. Santhosh Joseph, Senior Consultant & Clinical Lead, Neuro Interventional, KIMSHEALTH, Trivandrum.

"As an interventionalist, it gives me immense delight to see technologies evolving so rapidly especially in treating percutaneous coronary interventions or what is generally termed as narrowing of heart arteries. Technologies developed by Philips in this space, which many of us recently experienced, can potentially help interventionalists like us to dramatically decrease contrast and optimize radiation dose administration during the procedure ensuring both the safety and quality of PCI,” said Dr. T.S. Kler, Chairman & HOD, BLK-Max Heart & Vascular Institute, BLK-Max Super Speciality Hospital, Delhi.

Read more on how the new Azurion system is changing the world of surgery, here.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Click here to read more Click here to read less